Explore the Fingerprint Trends
Explore the Research Network
This is a list of publications by this organization, listed chronologically starting with the most recent first. The source of publications may be a combination of Scopus and manually entered data from a user. New publications from Scopus appear in this list weekly and publications entered by a user appear instantly. Citation counts start from 1996 and come directly from Scopus.
Tommy Sheu; John V. Heymach; Stephen G. Swisher; Ganesh Rao; Jeffrey S. Weinberg; Reza Mehran; Mary Frances McAleer; Zhongxing Liao; Thomas A. Aloia; Daniel R. Gomez
Propensity score-matched analysis of comprehensive local therapy for oligometastatic non-small cell lung cancer that did not progress after front-line chemotherapy
Shuhong Wu; Li Wang; Xiao Huang; Mengru Cao; Jing Hu; Hongyu Li; Hui Zhang; Xiaoping Sun; Qing H. Meng; Wayne L. Hofstetter; et al.
Prodrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380
Ara A. Vaporciyan
Apples and oranges: Understanding what our trainees need
Shinji Kuroda; Justina Tam; Jack A. Roth; Konstantin Sokolov; Rajagopal Ramesh
EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage
Shumei Song; Jaffer A. Ajani; Soichiro Honjo; Dipen M. Maru; Qiongrong Chen; Ailing W. Scott; Todd R. Heallen; Lianchun Xiao; Wayne L. Hofstetter; Brian Weston; et al.
Hippo coactivator YAP1 upregulates SOX9 and endows esophageal Cancer cells with stem-like properties
Takashi Taketa; Kazuki Sudo; Arlene M. Correa; Roopma Wadhwa; Hironori Shiozaki; Elena Elimova; Maria-Claudia Campagna; Mariela A. Blum; Heath D. Skinner; Ritsuko U. Komaki; et al.
Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma
Treatment of Clinical T2N0M0 Esophageal Cancer
X. Pu; L. Wang; J.Y. Chang; M.A.T. Hildebrandt; Y. Ye; C. Lu; H.D. Skinner; N. Niu; G.D. Jenkins; R. Komaki; et al.
Inflammation-Related Genetic Variants Predict Toxicity Following Definitive Radiotherapy for Lung Cancer
Kazuki Sudo; Elena Elimova; Heath D. Skinner; Wayne L. Hofstetter; Jaffer A. Ajani
Reply to R. Gertler et al
Robert Schier; Volker Schick; Ashley Amsbaugh; Jorge Aguilar; Mike Hernandez; Reza J. Mehran; Bernhard Riedel; Jochen Hinkelbein
Brachial artery reactivity and vascular reactive hyperemia for preoperative anaesthesia risk assessment - an observational study
Reza Mehran; Monique Nilsson; Mehrdad Khajavi; Zhiqiang Du; Tina Cascone; Hua Kang Wu; Andrea Cortes; Li Xu; Amado Zurita; Robert Schier; et al.
Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy
X Pu; M A T Hildebrandt; C Lu; J A Roth; D J Stewart; Y Zhao; R S Heist; Y Ye; D W Chang; L Su; et al.
Inflammation-Related Genetic Variations and Survival in Patients With Advanced Non-Small Cell Lung Cancer Receiving First-Line Chemotherapy
Jingya Wang; Jaipreet S. Suri; Pamela K. Allen; Zhongxing Liao; Ritsuko Komaki; Linus Ho; Wayne L. Hofstetter; Steven H. Lin
Factors predictive of improved outcomes with multimodality local therapy after palliative chemotherapy for stage IV esophageal cancer
Joe Y. Chang; Qiao-Qiao Li; Qing-Yong Xu; Pamela K. Allen; Neal Rebueno; Daniel R. Gomez; Peter Balter; Ritsuko Komaki; Reza Mehran; Stephen G. Swisher; et al.
Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: How to fly in a "no fly zone"
Kathryn A. Gold; Edward S. Kim; Diane D. Liu; Ping Yuan; Carmen Behrens; Luisa M. Solis; Humam Kadara; David C. Rice; Ignacio I. Wistuba; Stephen G. Swisher; et al.
Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: Implications for personalized chemoprevention and therapy
Andreas Rimner; Daniel R. Gomez; Abraham J. Wu; Weiji Shi; Ellen D. Yorke; Andre L. Moreira; David Rice; Ritsuko Komaki; Kenneth E. Rosenzweig; Gregory J. Riely; et al.
Failure patterns relative to radiation treatment fields for stage II-IV thymoma
Rishindra M. Reddy; Anthony W. Kim; David T. Cooke; Stephen C. Yang; Ara Vaporciyan; Robert S.D. Higgins
The looking to the future medical student program: Recruiting tomorrow's leaders
J.A. Ajani; X. Wang; S. Song; A. Suzuki; T. Taketa; K. Sudo; R. Wadhwa; W.L. Hofstetter; R. Komaki; D.M. Maru; et al.
ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients
J. Wang; B. Myles; C. Wei; J.Y. Chang; W.L. Hofstetter; J.A. Ajani; S.G. Swisher; J.D. Cox; R. Komaki; Z. Liao; et al.
Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma
Beatriz Sanchez-Espiridion; Meng Chen; Joe Y. Chang; Charles Lu; David W. Chang; Jack A. Roth; Xifeng Wu; Jian Gu
Telomere length in peripheral blood leukocytes and lung cancer risk: A large case-control study in caucasians